GenLumina is a Leiden biotech company creating light-activated DNA nanomedicines based on ultra-small DNA-encapsulated silver nanoclusters that target tumor cell nuclei. Activated by light to induce controlled cancer cell death while sparing healthy tissue, the platform minimizes side effects, leverages existing surgical equipment, and aims to transform global precision oncology.